Douglas Dynamics, Inc. (PLOW)

CTI BioPharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.21	5.12	24.16	20.67	36.96	41.03
Trading Asset Securities	1.49	1.71	3.17	4.12	-	-
Cash & Short-Term Investments	8.7	6.83	27.33	24.79	36.96	41.03
Cash Growth	72.81%	-75.00%	10.25%	-32.93%	-9.91%	15.04%
Accounts Receivable	69.22	87.41	83.76	86.77	71.04	83.2
Other Receivables	-	-	4.82	-	1.22	-
Receivables	69.22	87.41	88.58	86.77	72.26	83.2
Inventory	192.65	139.65	142.61	137.71	106.67	87.63
Prepaid Expenses	3.69	4.34	3.72	3.65	4.54	5.33
Total Current Assets	274.25	238.23	262.24	252.92	220.43	217.19
Property, Plant & Equipment	109.06	112.11	85.35	86.09	85.25	85.76
Long-Term Investments	0.18	0.63	0.86	2.92	-	-
Goodwill	113.13	113.13	113.13	113.13	113.13	113.13
Other Intangible Assets	112	113.55	121.07	131.59	142.11	152.79
Other Long-Term Assets	12.42	12.33	10.77	10.24	11.55	10.33
Total Assets	621.04	589.98	593.42	596.89	572.48	579.2
Accounts Payable	42.86	32.32	31.37	49.25	27.38	16.28
Accrued Expenses	12.78	16.27	13.71	19.67	22.23	17.88
Short-Term Debt	33.17	2.61	49.22	1.21	2.66	7.89
Current Portion of Long-Term Debt	7.42	-	6.76	11.14	14.62	5.74
Current Portion of Leases	7.19	7.39	5.35	4.86	4.62	4.33
Current Income Taxes Payable	1.61	1.69	-	3.49	-	5.21
Other Current Liabilities	10.75	9.92	12.11	10.82	10.42	8.87
Total Current Liabilities	115.78	70.19	118.52	100.43	81.92	66.21
Long-Term Debt	140.89	147.23	182.24	198.22	209.01	245.67
Long-Term Leases	62.64	64.79	13.89	14.03	15.41	17.43
Long-Term Deferred Tax Liabilities	24.61	24.57	27.9	29.84	29.79	26.68
Other Long-Term Liabilities	4.93	5.38	5.38	2.63	4.58	7.2
Total Liabilities	362.16	325.77	361.85	359.79	357.87	379
Common Stock	0.23	0.23	0.23	0.23	0.23	0.23
Additional Paid-In Capital	172.08	170.09	165.23	164.28	163.55	157.76
Retained Earnings	81.55	88.42	59.75	63.46	51.88	47.71
Comprehensive Income & Other	5.02	5.47	6.36	9.13	-1.05	-5.5
Shareholders' Equity	258.89	264.22	231.57	237.1	214.61	200.2
Total Liabilities & Equity	621.04	589.98	593.42	596.89	572.48	579.2
Total Debt	251.31	222.02	257.45	229.45	246.31	281.06
Net Cash (Debt)	-242.61	-215.19	-230.12	-204.66	-209.35	-240.03
Net Cash Per Share	-10.31	-9.15	-10.02	-8.93	-9.12	-10.51
Filing Date Shares Outstanding	23.21	23.09	22.98	22.89	22.98	22.86
Total Common Shares Outstanding	23.21	23.09	22.98	22.89	22.98	22.86
Working Capital	158.47	168.03	143.72	152.49	138.52	150.98
Book Value Per Share	11.15	11.44	10.08	10.36	9.34	8.76
Tangible Book Value	33.75	37.53	-2.64	-7.62	-40.63	-65.72
Tangible Book Value Per Share	1.45	1.63	-0.11	-0.33	-1.77	-2.88
Land	0.16	0.16	3.97	3.97	3.97	2.38
Buildings	2.96	2.96	36.72	35.86	34.64	29.58
Machinery	115.78	115.15	110.27	104.72	95.95	86.14
Construction In Progress	5.71	4.74	5.13	5.27	4.24	11.75
Leasehold Improvements	7.14	7.03	6.58	5.84	5.41	4.09
Order Backlog	-	348	296.3	-	-	-

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q